Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2
- PMID: 23774623
- DOI: 10.1016/j.bcp.2013.06.003
Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2
Abstract
Matrix metalloproteinase (MMP)-2, a zinc-dependent endopeptidase, plays a detrimental role in several diseases including ischemia and reperfusion (I/R) injury of the heart. Caspases are a group of cysteine-dependent, aspartate-directed proteases which regulate cellular apoptosis. Interestingly, protective effects of caspase inhibitors independent of apoptosis have been shown in I/R injury of the heart. The cardioprotective actions of both these classes of protease inhibitors led us to hypothesize that caspase inhibitors may also reduce MMP-2 activity. Five known caspase inhibitors (Z-IE(OMe)TD(OMe)-fmk, Ac-DEVD-CHO, Ac-LEHD-cmk, Z-VAD-fmk and Ac-YVAD-cmk) were tested for their possible inhibitory effects on MMP-2 activity in comparison to the MMP inhibitors ONO-4817 and ARP-100 (which themselves were unable to inhibit caspase-3 activity). MMP-2 activity was assessed by an in vitro troponin I (TnI) proteolysis assay and a quantitative kinetic fluorescence assay using a fluorogenic peptide substrate (OmniMMP). TnI proteolysis was also measured by western blot in neonatal cardiomyocytes subjected to hypoxia-reoxygenation injury. Using human recombinant MMP-2 and TnI as its substrate, the caspase inhibitors, in comparison with ONO-4817, significantly inhibited MMP-2-mediated TnI degradation in a concentration-dependent manner. The kinetic assay using OmniMMP revealed that these caspase inhibitors blocked MMP-2 activity in a concentration-dependent manner with similar IC50 values. TnI degradation in neonatal cardiomyocytes was enhanced following hypoxia-reoxygenation and this was blocked by ARP-100 and Ac-LEHD-cmk. Inhibition of MMP-2 activity is an additional pharmacological action which contributes to the protective effects of some caspase inhibitors.
Keywords: Caspase inhibitors; Caspases; Hypoxia-reoxygenation; I/R; MMPs; Matrix metalloproteinase-2; TnI; Troponin I; ischemia and reperfusion; matrix metalloproteinases; troponin I.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity.Biochem Biophys Res Commun. 2012 Jun 22;423(1):1-5. doi: 10.1016/j.bbrc.2012.05.005. Epub 2012 May 7. Biochem Biophys Res Commun. 2012. PMID: 22575511
-
Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.Can J Physiol Pharmacol. 2018 Dec;96(12):1238-1245. doi: 10.1139/cjpp-2018-0275. Epub 2018 Oct 11. Can J Physiol Pharmacol. 2018. PMID: 30308129
-
Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects.J Am Coll Cardiol. 2001 Dec;38(7):2063-70. doi: 10.1016/s0735-1097(01)01670-9. J Am Coll Cardiol. 2001. PMID: 11738316
-
Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches.Annu Rev Pharmacol Toxicol. 2007;47:211-42. doi: 10.1146/annurev.pharmtox.47.120505.105230. Annu Rev Pharmacol Toxicol. 2007. PMID: 17129183 Review.
-
Matrix metalloproteinase-2 as a target for head and neck cancer therapy.Expert Opin Ther Targets. 2013 Feb;17(2):203-16. doi: 10.1517/14728222.2013.740012. Epub 2012 Dec 19. Expert Opin Ther Targets. 2013. PMID: 23252422 Review.
Cited by
-
Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo.Acta Pharmacol Sin. 2021 Jul;42(7):1101-1110. doi: 10.1038/s41401-020-00534-y. Epub 2020 Oct 7. Acta Pharmacol Sin. 2021. PMID: 33028983 Free PMC article.
-
The roles of intracellular proteolysis in cardiac ischemia-reperfusion injury.Basic Res Cardiol. 2023 Sep 28;118(1):38. doi: 10.1007/s00395-023-01007-z. Basic Res Cardiol. 2023. PMID: 37768438 Review.
-
Identifying simultaneous matrix metalloproteinases/soluble epoxide hydrolase inhibitors.Mol Cell Biochem. 2022 Mar;477(3):877-884. doi: 10.1007/s11010-021-04337-5. Epub 2022 Jan 24. Mol Cell Biochem. 2022. PMID: 35067781
-
Myocardial matrix metalloproteinase-2: inside out and upside down.J Mol Cell Cardiol. 2014 Dec;77:64-72. doi: 10.1016/j.yjmcc.2014.09.016. Epub 2014 Sep 28. J Mol Cell Cardiol. 2014. PMID: 25261607 Free PMC article. Review.
-
Role of pyroptosis in the pathogenesis and treatment of diseases.MedComm (2020). 2023 Apr 25;4(3):e249. doi: 10.1002/mco2.249. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37125240 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous